By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MorphoSys AG 

Lena-Christ-Strasse 48

Martinsried  Munich  82152  Germany
Phone: 49-0-89-899-27-0 Fax: 49-0-89-899-27-222



Company News
MorphoSys AG Reports Results For The First Three Months Of 2016 5/3/2016 8:32:52 AM
MorphoSys AG To Host Q1 2016 Conference Call On May 3, 2016 4/27/2016 9:19:29 AM
MorphoSys AG Licensing Partner GlaxoSmithKline (GSK) Starts Phase 2 Study With GSK3196165 (MOR103) In Hand Osteoarthritis 4/18/2016 9:43:31 AM
Galapagos (GLPG.BR) And MorphoSys AG Initiate Phase I Study In Joint Antibody Program MOR106 4/7/2016 10:38:37 AM
MorphoSys AG Initiates Phase 2 Combination Trial Of MOR208 And Lenalidomide In Patients With Relapsed Or Refractory Diffuse Large B Cell Lymphoma (DLBCL) 4/6/2016 10:26:52 AM
MorphoSys AG Sues Janssen Biotech Inc. (JNJ) And Genmab A/S (GEN.CO) For Patent Infringement 4/4/2016 11:46:30 AM
MorphoSys AG Reports Results For Fiscal Year 2015 3/2/2016 9:09:56 AM
Invitation To Year End 2015 Conference Call Of MorphoSys AG On March 2, 2016 2/25/2016 9:46:18 AM
MorphoSys AG Announces Share Buy-Back Program 2/24/2016 10:12:37 AM
MorphoSys AG Announces Clinical Milestone For Start Of Bayer (BAY)'s Phase 2 Trial Designed To Support Registration Of Anetumab Ravtansine 1/26/2016 9:19:18 AM